Abstract
Background and ObjectivesAn interferon gene signature (IGS) is present in 20–30% of established rheumatoid arthritis (RA) patients where it does not correlate with disease activity. However immunomodulatory treatment may mask...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
